Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Burden of Blood Disorders
4.2.2 Increasing Technological Advancements
4.2.3 Rising Adoption Rates of Automated Hematology Instruments
4.3 Market Restraints
4.3.1 High Cost of Hematology Analyzers
4.3.2 Time-consuming and Stringent Rregulatory Policies
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Instruments
5.1.1.1 3 Part Hematology Analyzer
5.1.1.2 5 Part Hematology Analyzer
5.1.1.3 Point-of-Care Testing Hematology Analyzers
5.1.1.4 Others
5.1.2 Reagents
5.1.3 Services
5.2 By End User
5.2.1 Hospitals
5.2.2 Clinical Laboratories
5.2.3 Research Institutes
5.2.4 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Beckman Coulter, Inc.
6.1.3 Bio-Rad Laboratories
6.1.4 Boule Diagnostics AB
6.1.5 F. Hoffmann-La Roche Ltd
6.1.6 Horiba Ltd
6.1.7 Nihon Kohden Corporation
6.1.8 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
6.1.9 Siemens Healthineers
6.1.10 Sysmex Corporation


7 MARKET OPPORTUNITIES AND FUTURE TRENDS